Research programme: PPAR beta modulators - 7TM Pharma

Drug Profile

Research programme: PPAR beta modulators - 7TM Pharma

Latest Information Update: 07 Jul 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator 7TM Pharma
  • Class Small molecules
  • Mechanism of Action Peroxisome proliferator-activated receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Lipid metabolism disorders

Most Recent Events

  • 24 May 2006 CareX has been acquired and merged into 7TM Pharma
  • 28 Apr 2004 Preclinical trials in Lipid metabolism disorders in France (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top